SCHEMBL28646703

SCHEMBL28646703

CC(C)(CO)C[C@@H](CO)CC(C)(C)NC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28967225 0.75 ALOX15 (0.39) —
SCHEMBL29059455 0.75 CTSS (0.33) —
SCHEMBL28986536 0.73 — —
SCHEMBL28772124 0.73 MAPT (0.31) —
SCHEMBL29130087 0.73 CYP2D6 (0.32) —
SCHEMBL29059253 0.73 CYP2D6 (0.32) —
SCHEMBL15562350 0.73 CYP2D6 (0.32) —
SCHEMBL12698393 0.72 POLB (0.36) —
SCHEMBL2490315 0.71 — —
SCHEMBL28591507 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108699032-B Polycyclic TLR7/8 antagonists and their use in the treatment of immune disorders 默克专利有限公司 2022-07-22 — — CN disclosed
CN-113603675-A Polycyclic TLR7/8 antagonists and their use in the treatment of immune disorders 默克专利有限公司 2021-11-05 — — CN disclosed
Send feedback